Group One Trading
NAGE

Group One Trading’s Niagen Bioscience NAGE Stock Holding History

Group One Trading’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.4K Sell
17,100
-14,600
-46% -$78.8K ﹤0.01% 4962
2025
Q4 		$202K Sell
31,700
-3,500
-10% -$24.4K ﹤0.01% 4361
2025
Q3 		$328K Buy
35,200
+18,700
+113% +$189K ﹤0.01% 4133
2025
Q2 		$238K Buy
16,500
+14,600
+768% +$144K ﹤0.01% 4157
2025
Q1 		$13.1K Buy
1,900
+1,800
+1,800% +$11.3K ﹤0.01% 6088
2024
Q4 		$530 Sell
100
-20,800
-100% -$114K ﹤0.01% 6999
2024
Q3 		$76.3K Sell
20,900
-400
-2% -$1.26K ﹤0.01% 4380
2024
Q2 		$58.1K Sell
21,300
-12,300
-37% -$41.2K ﹤0.01% 4410
2024
Q1 		$117K Buy
33,600
+20,800
+163% +$38.5K ﹤0.01% 4025
2023
Q4 		$18.3K Hold
12,800
– – ﹤0.01% 5811
2023
Q3 		$18.7K Sell
12,800
-10,000
-44% -$15.6K ﹤0.01% 5935
2023
Q2 		$35.8K Buy
22,800
+12,800
+128% +$19.1K ﹤0.01% 5534
2023
Q1 		$15.3K Buy
10,000
+9,900
+9,900% +$17.6K ﹤0.01% 5690
2022
Q4 		$168 Sell
100
-26,600
-100% -$42.2K ﹤0.01% 7049
2022
Q3 		$33K Sell
26,700
-2,500
-9% -$4.02K ﹤0.01% 5740
2022
Q2 		$49K Buy
29,200
+1,500
+5% +$2.93K ﹤0.01% 5577
2022
Q1 		$68K Buy
27,700
+4,400
+19% +$12K ﹤0.01% 5863
2021
Q4 		$87K Sell
23,300
-52,900
-69% -$286K ﹤0.01% 5857
2021
Q3 		$478K Sell
76,200
-35,500
-32% -$293K ﹤0.01% 4234
2021
Q2 		$1.1M Sell
111,700
-237,300
-68% -$2.07M ﹤0.01% 3300
2021
Q1 		$3.26M Buy
+349,000
New +$2.77M ﹤0.01% 1945

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's NAGE Position: Q1 2026 in Review

Group One Trading increased its Niagen Bioscience (NAGE) stake by 73% in Q1 2026, buying an estimated $40.3K and bringing the position to 17,755 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4936.

Group One Trading first reported a position in NAGE in Q2 2016 and has held it in 21 quarters since. The position peaked at $5.78M in Q1 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Group One Trading held 17,755 shares of Niagen Bioscience worth $78.3K as of Q1 2026.
  • Group One Trading bought 7,470 Niagen Bioscience shares in Q1 2026, an estimated $40.3K.
  • Niagen Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4936 holding.
  • Group One Trading first reported a position in Niagen Bioscience in Q2 2016 and has held it in 21 quarters since.
  • Group One Trading's Niagen Bioscience position peaked at $5.78M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.